Source: ERS Course 2015
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
J. Chalmers (Dundee, United Kingdom), J. van Ingen (Nijmegen, Netherlands). Finding your way in the world of NTM pathogens. ERS Course 2015

Member's Comments

No comment yet.

Related content which might interest you: Looking into real world practice of elder pulmonary non-tuberculous mycobacterial infection. Source: International Congress 2019 – Clinical investigations of non-TB mycobacterial infection Year: 2019 Identifying patients with pneumonia due to MDR organisms coming from the community Source: Eur Respir Monogr 2017; 75: 97-110 Year: 2017 TB and emerging pandemic pathogens Source: ERS Course 2015 Year: 2015 Beyond pulmonary nontuberculous mycobacteria disease: do extra-pulmonary forms represent an emerging clinical and public health threat? Source: ERJ Open Res, 3 (3) 00091-2017; 10.1183/23120541.00091-2017 Year: 2017 Multidrug-resistant tuberculosis around the world: what progress has been made? Source: Eur Respir J 2015; 45: 150-160 Year: 2015 Predicting bacteraemia or rapid identification of the causative pathogen in community acquired pneumonia: where should the priority lie? Source: Eur Respir J 2016; 48: 619-622 Year: 2016 Novel approach to species identification of nontuberculous mycobacteria Source: Annual Congress 2010 - Nontuberculous mycobacterial infections and tuberculosis Year: 2010 Pathogenicity of NTM: new developments Source: Annual Congress 2007 - Nontuberculous mycobacteria (NTM): a slow-growing challenge Year: 2007 What is important for people with nontuberculous mycobacterial disease? An EMBARC-ELF patient survey Source: ERJ Open Res, 7 (1) 00807-2020; 10.1183/23120541.00807-2020 Year: 2021 Characterisation of patients with multiple isolates of different species of non-tuberculous mycobacteria: a new phenomenon? Source: Annual Congress 2009 - Extrapulmonary tuberculosis and non-tuberculous-mycobacteria (NTM) infections Year: 2009 From environmental bacteria to obligate pathogen: the study of adaptations enhancing the persistence of tuberculosis bacilli Source: Virtual Congress 2020 – Non-tuberculous mycobacteria and latent tuberculosis infection Year: 2020 From environmental bacteria to obligate pathogen: the study of adaptations enhancing the persistence of tuberculosis bacilli Source: International Congress 2019 – Tuberculosis: from basic science to patient care Year: 2019 Non-tuberculous mycobacteria in the environment and as human pathogens Source: Annual Congress 2011 - Non-tuberculous mycobacterial infections Year: 2011 Treatment of nontuberculous mycobacterial pulmonary diseases (fast-growing organisms): an interactive session Source: International Congress 2019 – New guidelines for treatment of nontuberculous mycobacterial pulmonary disease Year: 2019 Resistant pathogens that cause pneumonia: a global perspective Source: International Congress 2014 – Multidrug-resistant (MDR) pathogens that cause pneumonia Year: 2014 Treatment of nontuberculous mycobacterial pulmonary diseases (slow-growing organisms): an interactive session Source: International Congress 2019 – New guidelines for treatment of nontuberculous mycobacterial pulmonary disease Year: 2019 How important is work as a risk for lung infections? A story of tuberculosis and pneumonia Source: Virtual Congress 2020 – How much lung disease is really caused by work, and how to assess the worker who wishes to continue working? Year: 2020 Tuberculosis in the immunocompromised host: atypical TB? Source: Annual Congress 2006 - PG11 - Clinical highlights on tuberculosis Year: 2006 Non-tuberculous mycobacteria: how to treat these difficult infections Source: International Congress 2018 – State of the art session: Respiratory infections Year: 2018